Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.35
+0.38 (3.46%)
At close: May 12, 2025, 4:00 PM
10.73
-0.62 (-5.46%)
After-hours: May 12, 2025, 6:37 PM EDT
Mesoblast Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Mesoblast stock have an average target of 18, with a low estimate of 12 and a high estimate of 24. The average target predicts an increase of 58.59% from the current stock price of 11.35.
Analyst Consensus: Buy
* Price targets were last updated on Feb 7, 2025.
Analyst Ratings
The average analyst rating for Mesoblast stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Reiterates $15 → $24 | Buy | Reiterates | $15 → $24 | +111.45% | Feb 7, 2025 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $11 → $15 | Buy | Maintains | $11 → $15 | +32.16% | Dec 19, 2024 |
Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $12 | Hold → Strong Buy | Upgrades | $12 | +5.73% | Sep 24, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Aug 29, 2024 |
Financial Forecast
Revenue This Year
16.41M
from 5.90M
Increased by 178.09%
Revenue Next Year
66.48M
from 16.41M
Increased by 305.06%
EPS This Year
-0.40
from -0.09
EPS Next Year
-0.22
from -0.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 20.2M | 82.5M | 350.2M | ||
Avg | 16.4M | 66.5M | 243.2M | ||
Low | 12.7M | 56.8M | 100.9M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 241.6% | 402.8% | 426.7% | ||
Avg | 178.1% | 305.1% | 265.9% | ||
Low | 115.9% | 246.3% | 51.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | -0.07 | -0.05 | 0.14 | |
Avg | -0.40 | -0.22 | 0.01 | |
Low | -0.72 | -0.38 | -0.19 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.